Om Megashree Pharmaceuticals (OMPL) share price is Rs. 803.10, down 1.58% on 2026-11-02. Open Rs. 816.00. High Rs. 839.00. Low Rs. 802.00. Volume 1,330.
Om Megashree Pharmaceuticals Limited is a NEPSE-listed company (OMPL), Manufacturing And Processing sector. Revenue: Rs. 21.01 Crore. Net loss: Rs. 5.05 Crore. Net worth: Rs. 62.36 Crore.
Pharmaceutical manufacturer based in Kathmandu, Nepal (registered office: Kathmandu Metropolitan City, Ward 10, New Baneshwor). Holds an Investment in Subsidiary, so quarterly statements are presented on a group basis with Profit Attributable to Parent/NCI. Pursuing WHO-GMP certification and expansion into eye/ear drops and veterinary products.
Om Megashree Pharmaceuticals Limited (OMPL) has 60,00,000 shares outstanding.
| Market Cap | Rs. 481.86 Crore |
|---|---|
| P/E Ratio | 539.70 |
| EPS | Rs. 1.49 |
| Loss Per Share (TTM) | Rs. 8.42 |
| Book Value | Rs. 103.94 |
| Dividend Yield | 0.00% |
| Face Value | Rs. 100.00 |
| 52 Week High | Rs. 1,575.90 |
| 52 Week Low | Rs. 793.30 |
What Om Megashree Pharmaceuticals Limited's own accounts show in its favour, graded against the rest of its sector.
What the same accounts show against it. Both lists are computed from the filed figures, not opinion, and are not advice.
In the fourth quarter of 2082/83 (Q4 2082/83) Om Megashree Pharmaceuticals Limited reported profit of Rs. 0.32 crore and revenue from operations of Rs. 7.1 crore. Profit in Q3 2082/83 was a loss of Rs. 1.53 crore. Profit turned from a loss to a profit on the previous quarter. Revenue from operations grew 106.96% on the previous quarter. Profit in Q4 2081/82, the same quarter a year earlier, was Rs. 0.14 crore. Profit grew 134.81% on the same quarter last year. Revenue from operations grew 13.28% on the same quarter last year.
For the financial year 2082/83 Om Megashree Pharmaceuticals Limited reported a net loss of Rs. 5.05 crore, revenue from operations of Rs. 21.01 crore and net worth of Rs. 62.36 crore. Net profit in 2081/82 was Rs. 0.89 crore. Net profit turned from a profit to a loss on the year. Revenue from operations fell 24.30% on the year.
In the financial year 2082/83, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 21.01 crore, gross profit of Rs. 12.8 crore, operating profit of Rs. 1.49 crore, profit before tax of Rs. 5.05 crore and net profit for the year of Rs. 5.05 crore.
Reported under gross profit: cost of sales of Rs. 8.21 crore. Reported under operating profit: other income of Rs. 0.15 crore, administrative expenses of Rs. 6.98 crore and depreciation and amortisation of Rs. 4.47 crore. Reported under profit before tax: finance costs of Rs. 6.54 crore.
In the financial year 2081/82, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 27.76 crore, gross profit of Rs. 17.94 crore, operating profit of Rs. 7.61 crore, profit before tax of Rs. 1.15 crore and net profit for the year of Rs. 0.89 crore.
Reported under gross profit: cost of sales of Rs. 9.81 crore. Reported under operating profit: other income of Rs. 0.04 crore, selling and distribution expenses of Rs. 0 crore, administrative expenses of Rs. 6.05 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 4.32 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 6.46 crore. Reported under net profit for the year: deferred tax of Rs. 0.26 crore.
In the financial year 2080/81, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 9.12 crore, gross profit of Rs. 6.43 crore, operating profit of Rs. 3.14 crore, profit before tax of Rs. 1.8 crore and net profit for the year of Rs. 1.44 crore.
Reported under gross profit: cost of sales of Rs. 2.7 crore. Reported under operating profit: other income of Rs. 0.03 crore, selling and distribution expenses of Rs. 0.37 crore, administrative expenses of Rs. 0.79 crore, employee benefit expenses of Rs. 1.27 crore, depreciation and amortisation of Rs. 0.88 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 1.35 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 0.35 crore and prior period tax adjustment of Rs. 0 crore.
In the financial year 2081/82, Om Megashree Pharmaceuticals Limited reported total non-current assets of Rs. 103.95 crore, total current assets of Rs. 36.96 crore, total equity of Rs. 62.36 crore, total non-current liabilities of Rs. 55.66 crore and total current liabilities of Rs. 22.89 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 102.35 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 1.11 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0.5 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 1.51 crore, trade receivables of Rs. 0 crore, cash and cash equivalents of Rs. 0.23 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 0 crore, income tax assets (net) of Rs. 0.01 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 34.66 crore and other current assets of Rs. 0.55 crore. Reported under total equity: share capital of Rs. 60 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 0 crore, retained earnings of Rs. 3.88 crore, other equity of Rs. 6.24 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 54.27 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 1.39 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 19.06 crore, trade payables of Rs. 0 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0.4 crore, other financial liabilities of Rs. 3.43 crore, other current liabilities of Rs. 0 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
In the financial year 2080/81, Om Megashree Pharmaceuticals Limited reported total non-current assets of Rs. 97.54 crore, total current assets of Rs. 12.24 crore, total equity of Rs. 44.08 crore, total non-current liabilities of Rs. 56.11 crore and total current liabilities of Rs. 9.6 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 96.33 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 1.22 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 1.08 crore, trade receivables of Rs. 0 crore, cash and cash equivalents of Rs. 0.36 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 0 crore, income tax assets (net) of Rs. 0.01 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 9.26 crore and other current assets of Rs. 1.54 crore. Reported under total equity: share capital of Rs. 42 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 0 crore, retained earnings of Rs. 4.16 crore, other equity of Rs. 6.24 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 54.98 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 1.13 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 7.15 crore, trade payables of Rs. 0 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0.56 crore, other financial liabilities of Rs. 1.89 crore, other current liabilities of Rs. 0 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
In the financial year 2079/80, Om Megashree Pharmaceuticals Limited reported total non-current assets of Rs. 82.75 crore, total current assets of Rs. 2.51 crore, total equity of Rs. 35.72 crore, total non-current liabilities of Rs. 47.23 crore and total current liabilities of Rs. 2.31 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 82.75 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 0.24 crore, trade receivables of Rs. 0 crore, cash and cash equivalents of Rs. 0.35 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 0 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0.22 crore and other current assets of Rs. 1.7 crore. Reported under total equity: share capital of Rs. 20 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 6.22 crore, retained earnings of Rs. 5.5 crore, other equity of Rs. 15 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 46.46 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 0.77 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 0.25 crore, trade payables of Rs. 0 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0.71 crore, other financial liabilities of Rs. 1.36 crore, other current liabilities of Rs. 0 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
In the financial year 2080/81, Om Megashree Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.35 crore, net cash from operating activities of Rs. 1.49 crore, net cash from investing activities of Rs. 15.67 crore, net cash from financing activities of Rs. 14.18 crore, net change in cash of Rs. 0 crore and closing cash & cash equivalents of Rs. 0.36 crore.
Reported under net cash from operating activities: profit before tax of Rs. 1.8 crore, adjustment for depreciation and amortisation of Rs. 0.88 crore, adjustment for finance costs of Rs. 1.35 crore, changes in working capital of Rs. 2.44 crore and other operating adjustments of Rs. 0.09 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 89.28 crore and additions to capital work in progress of Rs. 73.61 crore. Reported under net cash from financing activities: proceeds from issue of share capital of Rs. 22 crore, proceeds from borrowings of Rs. 8.52 crore, interest paid of Rs. 1.35 crore and other financing activities of Rs. 15 crore.
In the financial year 2079/80, Om Megashree Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.29 crore, net cash from operating activities of Rs. 2.24 crore, net cash from investing activities of Rs. 15.48 crore, net cash from financing activities of Rs. 17.79 crore, net change in cash of Rs. 0.07 crore and closing cash & cash equivalents of Rs. 0.35 crore.
Reported under net cash from operating activities: profit before tax of Rs. 1.31 crore and adjustment for depreciation and amortisation of Rs. 0.23 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 0.16 crore and additions to capital work in progress of Rs. 15.32 crore. Reported under net cash from financing activities: proceeds from issue of share capital of Rs. 11.74 crore, proceeds from borrowings of Rs. 6.07 crore and other financing activities of Rs. 0.02 crore.
In the financial year 2078/79, Om Megashree Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.19 crore, net cash from operating activities of Rs. 0.44 crore, net cash from investing activities of Rs. 16.21 crore, net cash from financing activities of Rs. 15.87 crore, net change in cash of Rs. 0.1 crore and closing cash & cash equivalents of Rs. 0.29 crore.
Reported under net cash from operating activities: profit before tax of Rs. 0.74 crore and adjustment for depreciation and amortisation of Rs. 0.23 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 0.13 crore.
In the quarter Q4 2082/83, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 7.1 crore, gross profit of Rs. 4.18 crore, operating profit of Rs. 1.6 crore, profit before tax of Rs. 0.32 crore and net profit for the year of Rs. 0.32 crore.
Reported under gross profit: cost of sales of Rs. 2.92 crore. Reported under operating profit: other income of Rs. 0.04 crore, administrative expenses of Rs. 1.46 crore and depreciation and amortisation of Rs. 1.15 crore. Reported under profit before tax: finance costs of Rs. 1.28 crore.
In the quarter Q3 2082/83, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 3.43 crore, gross profit of Rs. 2.57 crore, operating profit of Rs. 0.33 crore, profit before tax of Rs. 1.53 crore and net profit for the year of Rs. 1.53 crore.
Reported under gross profit: cost of sales of Rs. 0.86 crore. Reported under operating profit: other income of Rs. 0.08 crore, administrative expenses of Rs. 1.87 crore and depreciation and amortisation of Rs. 1.12 crore. Reported under profit before tax: finance costs of Rs. 1.19 crore.
In the quarter Q2 2082/83, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 5.33 crore, gross profit of Rs. 2.77 crore, operating profit of Rs. 0.48 crore, profit before tax of Rs. 1.54 crore and net profit for the year of Rs. 1.54 crore.
Reported under gross profit: cost of sales of Rs. 2.56 crore. Reported under operating profit: other income of Rs. 0.02 crore, administrative expenses of Rs. 1.12 crore and depreciation and amortisation of Rs. 1.19 crore. Reported under profit before tax: finance costs of Rs. 2.02 crore.
In the quarter Q1 2082/83, Om Megashree Pharmaceuticals Limited reported revenue from operations of Rs. 5.15 crore, gross profit of Rs. 3.28 crore, operating profit of Rs. 0.26 crore, profit before tax of Rs. 2.31 crore and net profit for the year of Rs. 2.31 crore.
Reported under gross profit: cost of sales of Rs. 1.88 crore. Reported under operating profit: other income of Rs. 0.01 crore, administrative expenses of Rs. 2.54 crore and depreciation and amortisation of Rs. 1 crore. Reported under profit before tax: finance costs of Rs. 2.05 crore.
Values in Rs. Crore unless stated otherwise.
| Particulars | 2082/83 | 2081/82 | 2080/81 | 2079/80 | 2078/79 | 2077/78 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 21.0 | 27.8 | 9.1 | 0.00 | Not reported | Not reported |
| Gross Profit | 12.8 | 17.9 | 6.4 | 0.00 | Not reported | Not reported |
| Cost of Sales | -8.2 | -9.8 | -2.7 | 0.00 | Not reported | Not reported |
| Operating Profit | 1.5 | 7.6 | 3.1 | -1.3 | Not reported | Not reported |
| Other Income | 0.15 | 0.04 | 0.03 | 0.02 | 0.11 | Not reported |
| Selling and Distribution Expenses | Not reported | 0.00 | -0.37 | -0.03 | Not reported | Not reported |
| Administrative Expenses | -7.0 | -6.1 | -0.79 | -0.56 | Not reported | Not reported |
| Employee Benefit Expenses | Not reported | 0.00 | -1.3 | -0.55 | -0.20 | Not reported |
| Depreciation and Amortisation | -4.5 | -4.3 | -0.88 | -0.20 | -0.23 | -0.22 |
| Allowance for Expected Credit Loss | Not reported | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Other Operating Expenses | Not reported | 0.00 | 0.00 | 0.00 | -0.42 | Not reported |
| Profit Before Tax | -5.1 | 1.2 | 1.8 | -1.3 | -0.74 | -0.22 |
| Finance Costs | -6.5 | -6.5 | -1.3 | 0.00 | Not reported | Not reported |
| Gain on Investments through Fair Value | Not reported | Not reported | 0.00 | 0.00 | Not reported | Not reported |
| Net Profit for the Year | -5.1 | 0.89 | 1.4 | -1.1 | -0.61 | -0.22 |
| Current Tax | Not reported | Not reported | -0.00 | 0.00 | Not reported | 0.00 |
| Deferred Tax | Not reported | -0.26 | -0.35 | 0.23 | 0.14 | 0.00 |
| Prior Period Tax Adjustment | Not reported | Not reported | 0.00 | 0.00 | Not reported | 0.00 |
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 | 2078/79 | 2077/78 |
|---|---|---|---|---|---|
| Total Non-Current Assets | 104 | 97.5 | 82.8 | 67.4 | 51.4 |
| Property, Plant and Equipment | 102 | 96.3 | 82.8 | 67.4 | 51.4 |
| Capital Work-in-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1.1 | 1.2 | 0.00 | 0.00 | 0.00 |
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investment in Quoted Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investment in Subsidiaries | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financial Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 37.0 | 12.2 | 2.5 | 0.91 | 2.9 |
| Inventories | 1.5 | 1.1 | 0.24 | Not reported | Not reported |
| Trade Receivables | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Cash and Cash Equivalents | 0.23 | 0.36 | 0.35 | 0.29 | 0.19 |
| Bank Balance (other than Cash and Cash Equivalents) | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Advances | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Income Tax Assets (Net) | 0.01 | 0.01 | 0.00 | 0.00 | Not reported |
| Investments in Fixed Deposit | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Prepayments | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Other Financial Assets | 34.7 | 9.3 | 0.22 | 0.22 | 0.60 |
| Other Current Assets | 0.55 | 1.5 | 1.7 | 0.40 | 2.1 |
| Total Equity | 62.4 | 44.1 | 35.7 | 25.0 | 14.2 |
| Share Capital | 60.0 | 42.0 | 20.0 | 20.0 | 10.0 |
| Share Premium Reserve | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reserve and Surplus | 0.00 | 0.00 | 6.2 | 6.2 | 6.2 |
| Retained Earnings | -3.9 | -4.2 | -5.5 | -4.4 | -3.8 |
| Other Equity | 6.2 | 6.2 | 15.0 | 3.3 | 1.8 |
| Non-Controlling Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 55.7 | 56.1 | 47.2 | 41.8 | 37.4 |
| Long Term Borrowings | 54.3 | 55.0 | 46.5 | 40.6 | 36.2 |
| Lease Liabilities | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Deferred Tax Liabilities (Net) | 1.4 | 1.1 | 0.77 | 0.99 | 1.1 |
| Retirement Benefit Obligation | 0.00 | 0.00 | 0.00 | 0.19 | 0.06 |
| Other Financial Liabilities | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Provisions | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Total Current Liabilities | 22.9 | 9.6 | 2.3 | 1.5 | 2.7 |
| Short Term Borrowings | 19.1 | 7.1 | 0.25 | Not reported | Not reported |
| Trade Payables | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Lease Liabilities | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Retirement Benefit Obligation | 0.40 | 0.56 | 0.71 | Not reported | Not reported |
| Other Financial Liabilities | 3.4 | 1.9 | 1.4 | 1.5 | 2.7 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Provisions | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
| Income Tax Liabilities (Net) | 0.00 | 0.00 | 0.00 | Not reported | Not reported |
Values in Rs. Crore unless stated otherwise.
| Particulars | 2080/81 | 2079/80 | 2078/79 | 2077/78 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0.35 | 0.29 | 0.19 | 0.04 |
| Net Cash from Operating Activities | 1.5 | -2.2 | 0.44 | -5.7 |
| Profit Before Tax | 1.8 | -1.3 | -0.74 | -0.22 |
| Adjustment for Depreciation and Amortisation | 0.88 | 0.23 | 0.23 | 0.22 |
| Adjustment for Finance Costs | 1.3 | Not reported | Not reported | Not reported |
| Changes in Working Capital | -2.4 | Not reported | Not reported | Not reported |
| Other Operating Adjustments | -0.09 | Not reported | Not reported | Not reported |
| Net Cash from Investing Activities | -15.7 | -15.5 | -16.2 | -12.0 |
| Purchase of Property, Plant and Equipment | -89.3 | -0.16 | -0.13 | -0.90 |
| Additions to Capital Work in Progress | 73.6 | -15.3 | Not reported | Not reported |
| Net Cash from Financing Activities | 14.2 | 17.8 | 15.9 | 17.9 |
| Proceeds from Issue of Share Capital | 22.0 | 11.7 | Not reported | Not reported |
| Proceeds from Borrowings | 8.5 | 6.1 | Not reported | Not reported |
| Interest Paid | -1.3 | Not reported | Not reported | Not reported |
| Other Financing Activities | -15.0 | -0.02 | Not reported | Not reported |
| Net Change in Cash | 0.00 | 0.07 | 0.10 | 0.15 |
| Closing Cash & Cash Equivalents | 0.36 | 0.35 | 0.29 | 0.19 |
Figures from Om Megashree Pharmaceuticals Limited's quarterly reports, most recent quarter first.
Values in Rs. Crore unless stated otherwise.
| Particulars | Q4 2082/83 | Q3 2082/83 | Q2 2082/83 | Q1 2082/83 | Q4 2081/82 | Q3 2081/82 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 7.1 | 3.4 | 5.3 | 5.2 | 6.3 | 7.9 |
| Gross Profit | 4.2 | 2.6 | 2.8 | 3.3 | 4.3 | 4.6 |
| Cost of Sales | -2.9 | -0.86 | -2.6 | -1.9 | -1.9 | -3.3 |
| Operating Profit | 1.6 | -0.33 | 0.48 | -0.26 | Not reported | 1.7 |
| Other Income | 0.04 | 0.08 | 0.02 | 0.01 | 0.02 | 0.01 |
| Administrative Expenses | -1.5 | -1.9 | -1.1 | -2.5 | -1.2 | -1.9 |
| Depreciation and Amortisation | -1.2 | -1.1 | -1.2 | -1.0 | -1.1 | -1.1 |
| Profit Before Tax | 0.32 | -1.5 | -1.5 | -2.3 | 0.20 | 0.11 |
| Finance Costs | -1.3 | -1.2 | -2.0 | -2.0 | -1.8 | -1.6 |
| Net Profit for the Year | 0.32 | -1.5 | -1.5 | -2.3 | 0.14 | 0.34 |
| Deferred Tax | Not reported | Not reported | Not reported | Not reported | -0.06 | 0.23 |
Over the last 15 trading sessions OMPL closed between Rs. 800.00 and Rs. 855.00, finishing at Rs. 803.10 on 2026-11-02 against Rs. 855.00 on 2026-10-05.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2026-11-02 | 816.00 | 839.00 | 802.00 | 803.10 | 1,330 |
| 2026-10-30 | 820.00 | 849.00 | 815.00 | 816.00 | 2,563 |
| 2026-10-29 | 801.00 | 815.00 | 801.00 | 814.90 | 5,078 |
| 2026-10-28 | 798.00 | 815.00 | 793.30 | 800.00 | 2,174 |
| 2026-10-27 | 795.00 | 808.00 | 795.00 | 800.00 | 1,645 |
| 2026-10-26 | 815.00 | 815.00 | 800.00 | 810.00 | 770 |
| 2026-10-16 | 798.00 | 819.90 | 798.00 | 815.00 | 1,147 |
| 2026-10-14 | 807.00 | 820.00 | 807.00 | 819.90 | 1,547 |
| 2026-10-13 | 800.00 | 826.00 | 800.00 | 826.00 | 4,790 |
| 2026-10-12 | 820.00 | 844.60 | 801.10 | 818.00 | 4,476 |
| 2026-10-09 | 849.00 | 849.00 | 810.00 | 820.00 | 5,159 |
| 2026-10-08 | 875.00 | 875.00 | 820.00 | 828.00 | 5,979 |
| 2026-10-07 | 835.00 | 845.00 | 835.00 | 845.00 | 2,355 |
| 2026-10-06 | 845.00 | 869.90 | 840.00 | 848.00 | 2,943 |
| 2026-10-05 | 867.00 | 899.00 | 842.10 | 855.00 | 1,729 |
2026, between Rs. 793.30 and Rs. 1,575.90 and 2025, between Rs. 270.00 and Rs. 2,167.20.
| Year | Low (Rs.) | High (Rs.) | Sessions |
|---|---|---|---|
| 2026 | 793.30 | 1,575.90 | 190 |
| 2025 | 270.00 | 2,167.20 | 148 |
At Rs. 803.10 on 2026-11-02, OMPL is down 0.85% over 1 week, down 7.37% over 1 month, down 13.46% over 3 months, down 28.93% over 6 months and down 36.41% over 1 year. Each return compares that close with the last close on or before the same date in the earlier period.
| Period | Return | From price (Rs.) | From date |
|---|---|---|---|
| 1 week | -0.85% | 810.00 | 2026-10-26 |
| 1 month | -7.37% | 867.00 | 2026-10-02 |
| 3 months | -13.46% | 928.00 | 2026-08-04 |
| 6 months | -28.93% | 1,130.00 | 2026-05-06 |
| 1 year | -36.41% | 1,263.00 | 2025-11-02 |
OMPL traded 60 times on 2026-11-02, moving 1,330 shares for Rs. 0.11 crore of turnover. Trades went through between Rs. 802.00 and Rs. 839.00.
Largest buyers by volume: broker 58, Naasa Securities Co. Ltd. on 170 shares across 8 trades, broker 68, Elite Stock House Limited on 120 shares across 3 trades, broker 42, Sani Securities Company Limited on 105 shares across 2 trades, broker 7, J.F. Securities Company Pvt. Limited on 100 shares across 7 trades, broker 82, N.M.B. Securities Limited on 100 shares across 4 trades, broker 57, Arya Tara Investment And Securities Pvt. Ltd. on 100 shares across 3 trades, broker 13, Thrive Brokerage House Pvt. Limited on 100 shares across 2 trades, broker 67, Property Wizard Limited on 91 shares across 9 trades, broker 45, Imperial Securities Co. Limited on 90 shares across 2 trades and broker 25, Sweta Securities Pvt. Limited on 55 shares across 1 trades.
Largest sellers by volume: broker 38, Dipshika Dhitopatra Karobar Co. Pvt.Limited on 230 shares across 8 trades, broker 34, Vision Securities Pvt.Limited on 220 shares across 4 trades, broker 22, Siprabi Securities Pvt. Limited on 210 shares across 5 trades, broker 54, Sewa Securities Pvt. Ltd. on 150 shares across 5 trades, broker 11, Malla & Malla Stock Broking Company Pvt. Limited on 110 shares across 4 trades, broker 58, Naasa Securities Co. Ltd. on 70 shares across 7 trades, broker 59, Deevyaa Securities & Stock House Pvt. Ltd on 50 shares across 2 trades, broker 4, Stock Broker Opal Securities Investment Pvt. Limited on 40 shares across 2 trades, broker 49, Online Securities Limited on 40 shares across 4 trades and broker 25, Sweta Securities Pvt. Limited on 30 shares across 1 trades.
Annual and special general meetings Om Megashree Pharmaceuticals Limited has called. A dividend is declared by the board and approved at the AGM.
6 years of annual statements and 6 quarters of results for OMPL, with charts and peer comparison, are free on NepView.
New to these statements? How to read a profit and loss statement, How to read a balance sheet, How to read a cash flow statement, How to read quarterly results.
All manufacturing and processing companies on NEPSE